Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapyG Catimel, F Chauvin, J P Guastalla, et al.
Revue De Pneumologie Clinique|November 13, 2004
[Do combinations without cisplatin represent an alternative to conventional chemotherapy in non-small cell lung cancers?]J-L Pujol, W Jacot, J-L Breton, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Pharmacokinetically guided dosing for intravenous melphalan: a pilot study in patients with advanced ovarian adenocarcinomaD Y Ploin, B Tranchand, J P Guastalla, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gefitinib (IRESSA) with vinorelbine or vinorelbine/cisplatin for chemotherapy-naive non-small cell lung cancer patientsJean-Louis Pujol, Patrick Viens, Paul Rebattu, et al.
American Journal of Clinical Oncology|February 24, 2001
Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primaryE Voog, Y Merrouche, V Trillet-Lenoir, et al.
Presse Medicale (Paris, France : 1983)|May 5, 1990
[C-peptide assays of the urine and plasma at baseline and under stimulation with glucagon in healthy subjects and diabetics]O Sabot, J Tourniaire, A Charrie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase I antiemetic study of MDL 73,147EF, a novel 5-hydroxytryptamine antagonist in cancer patients receiving emetogenic chemotherapyY Merrouche, G Catimel, P Rebattu, et al.
Diabete & Metabolisme|February 1, 1986
Regulation of peripheral plasma somatostatin like immunoreactivity in type I diabetes: role of the degree of metabolic controlM Beylot, J A Chayvialle, B Rebattu, et al.
Eye (London, England)|January 13, 2023
Corneal foreign bodies: are antiseptics and antibiotics equally effective?Benjamin Rebattu, Stéphanie Baillif, Thierry Ferrete, et al.
Bulletin Du Cancer|January 1, 1993
[Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers]P J Souquet, P Fournel, M Jorda, et al.
Pageof 6